Pay in 4 interest-free payments of $5.14 Learn more
Ships within 48 hours · Estimated delivery Sep 27 - Oct 2
Weight loss in the first week is generally minimal and should not be used as a primary indicator of treatment success
ATC plaque: atherosclerotic plaque
Exenatide once weekly plus dapagliflozin once daily versus exenatide or dapagliflozin alone in patients with type 2 diabetes inadequately controlled with metformin monotherapy (DURATION-8): a 28 week, multicentre, double-blind, phase 3, randomised controlled trial
Studies show that discontinuing GLP-1 therapy after achieving weight loss often results in weight regain, making long-term consistent dosing essential for sustained results
:max_bytes(150000):strip_icc()/health-GettyImages-2025836701-ce3f5ccf0f98428e9d14abaeb07ba307.jpg)
US$ 24.48
US$ 24.41
US$ 21.52
